PCA3 is the news just a few quick comments; Pca3 is what will move this stock... how they have handled GCC was a mistake from the start, the lab was a big expense and they had other options but it was a positive they were relieved from that when Signal came on. I look for Signal to pay them in full or CUR will find a new company to partner with which will be a positive down the road. All of this still does not excuse how badly this was handled on the conference call.
I mentioned this briefly in a past post; the revenue that CUR posts from pca3 is so far behind that it is irrevelant, it is meaningless. They did a poor job on the call other than to say that it is Now 6 months behind. Thats prior to FDA approval. Hologic spoke about updates in November and I hope that they are able to clear things up at that time.
For now, we are all in the dark, and thats why we are seeing the selling, fear of the unknown. (CUR is also in the dark) What is known is that pca3 is being used on a regular basis at Leading Institutions here in the U.S. All one has to do is look at the top rated hospitals in urology and look at their websites.
Revenue will show a spike at some point once we get caught up, but my fear by that time is that CUR will be acquired at a much lower price than deserved.
I don't blame anyone for selling because this is frustrating and has been for a long time, but the studies don't lie and Hologic will announce their plans at some point this year and we will bounce back to FDA approval levels.